Hayato Hikita Selected Research

N-propionyl-L-valine (A 195)

1/2022

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hayato Hikita Research Topics

Disease

35	Hepatocellular Carcinoma (Hepatoma) 12/2022 - 05/2010
21	Neoplasms (Cancer) 12/2022 - 12/2008
16	Infections 06/2022 - 08/2011
12	Liver Cirrhosis (Hepatic Cirrhosis) 10/2022 - 06/2010
10	Chronic Hepatitis C 01/2022 - 01/2016
7	Fibrosis (Cirrhosis) 10/2022 - 03/2011
7	Inflammation (Inflammations) 11/2021 - 02/2010
5	Hepatitis C 06/2022 - 12/2017
4	Non-alcoholic Fatty Liver Disease 11/2021 - 01/2016
4	Hepatitis 01/2021 - 01/2007
3	Carcinogenesis 01/2022 - 08/2015
3	Liver Diseases (Liver Disease) 01/2022 - 08/2015
3	Fatty Liver 01/2021 - 07/2017
3	Adenocarcinoma 01/2020 - 07/2017
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 01/2019
3	Cholestasis 03/2011 - 01/2008
3	Chronic Hepatitis (Chronic Active Hepatitis) 03/2010 - 10/2008
2	Disease Progression 02/2022 - 05/2021
2	Virus Diseases (Viral Diseases) 01/2022 - 11/2015
2	Anemia 08/2019 - 02/2010
2	Massive Hepatic Necrosis 10/2018 - 01/2007
2	Pancreatitis 01/2018 - 12/2012
1	Cholangiocarcinoma 01/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Situs Inversus 01/2022
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2021

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2010
14	Antiviral Agents (Antivirals)IBA 10/2022 - 12/2017
6	Fetal Proteins (Fetoprotein)IBA 12/2022 - 10/2017
6	Biomarkers (Surrogate Marker)IBA 02/2022 - 01/2016
6	Sorafenib (BAY 43-9006)FDA Link 04/2021 - 05/2010
6	SofosbuvirIBA 01/2021 - 11/2015
5	RNA (Ribonucleic Acid)IBA 05/2022 - 01/2017
5	InterferonsIBA 10/2020 - 03/2016
5	Small Interfering RNA (siRNA)IBA 07/2017 - 10/2010
4	lenvatinibIBA 07/2022 - 11/2019
4	Glycoproteins (Glycoprotein)IBA 11/2021 - 03/2011
4	BilirubinIBA 09/2020 - 10/2009
4	sofosbuvir drug combination ledipasvirIBA 05/2020 - 12/2017
4	Transcription Factors (Transcription Factor)IBA 01/2020 - 12/2012
4	Ribavirin (Virazole)FDA LinkGeneric 08/2019 - 03/2016
3	atezolizumabIBA 07/2022 - 02/2022
3	Bevacizumab (Avastin)FDA Link 07/2022 - 02/2022
3	Phosphotransferases (Kinase)IBA 01/2022 - 10/2010
3	Growth Differentiation Factor 15IBA 01/2022 - 01/2021
3	Acetylcysteine (Siran)FDA LinkGeneric 01/2021 - 08/2015
3	ledipasvirIBA 01/2021 - 11/2015
3	SimeprevirIBA 07/2017 - 03/2016
3	Lamivudine (Epivir)FDA Link 05/2009 - 06/2008
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2016
2	LipidsIBA 01/2022 - 12/2016
2	pgRNAIBA 01/2022 - 01/2020
2	Warfarin (Coumadin)FDA LinkGeneric 01/2022 - 11/2019
2	Hyaluronic Acid (Hyaluronan)IBA 01/2022 - 11/2021
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2022 - 01/2016
2	CytokinesIBA 01/2022 - 11/2015
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 11/2021 - 01/2016
2	Nonesterified Fatty Acids (NEFA)IBA 01/2021 - 07/2017
2	daclatasvirIBA 05/2020 - 01/2020
2	asunaprevirIBA 05/2020 - 01/2020
2	micaIBA 10/2019 - 09/2012
2	VaccinesIBA 10/2018 - 12/2008
2	Lipase (Acid Lipase)FDA Link 01/2018 - 12/2012
2	Connective Tissue Growth FactorIBA 01/2018 - 08/2011
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2016 - 08/2015
2	CholesterolIBA 01/2016 - 11/2014
2	NucleotidesIBA 11/2015 - 01/2007
2	Cytostatic AgentsIBA 08/2012 - 10/2010
2	MicroRNAs (MicroRNA)IBA 08/2011 - 05/2010
2	Collagen Type I (Type I Collagen)IBA 03/2011 - 06/2010
1	Prothrombin (Factor II)IBA 12/2022
1	Immune Checkpoint InhibitorsIBA 03/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 03/2022
1	Interleukin-6 (Interleukin 6)IBA 02/2022
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2022
1	DNA Ligases (Ligases, DNA)IBA 01/2022
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 01/2022
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2022
1	Collagen Type IV (Type IV Collagen)IBA 01/2022
1	Hepatitis B e AntigensIBA 01/2022
1	Serum Amyloid P-ComponentIBA 01/2022
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2022
1	Ethanol (Ethyl Alcohol)IBA 01/2022
1	N-propionyl-L-valine (A 195)IBA 01/2022
1	3,7,11,15- tetramethyl- 2,4,6,10,14- hexadecapentaenoic acidIBA 01/2022
1	thrombospondin 2IBA 11/2021
1	RamucirumabIBA 04/2021
1	tyrosine receptor (receptor, tyrosine)IBA 01/2021
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021

Therapy/Procedure

18	Therapeutics 03/2022 - 06/2008
3	Immunotherapy 05/2022 - 09/2013
1	Radiofrequency Ablation 12/2022
1	Drug Therapy (Chemotherapy) 07/2022
1	Fontan Procedure (Fontan Operation) 01/2022
1	Radiotherapy 01/2022
1	Molecular Targeted Therapy 01/2021
1	Hepatectomy 01/2021